Go Tajima, M.D., Ph.D. Chief, Division of Neonatal Screening, Research Institute, National Center for Child Health and Development (NCCHD), Tokyo, Japan Dr. Tajima graduated from Hiroshima University School of Medicine in 1995. He worked as a pediatrician at Hiroshima University Hospital, Hiroshima City Hospital, and Sera Central Hospital from 1995 to 2001. Subsequently, he received research training at the Department of Pediatrics, Hiroshima University Graduate School of Medicine from 2001 to 2005. After obtaining a Ph.D., he worked as an Assistant Professor/Lecturer at Hiroshima University Graduate School of Biomedical and Health Sciences majoring in newborn screening for inborn errors of metabolism. In 2016, he moved to NCCHD and has since worked for the nationwide newborn screening program. At present, he is a vice president of the Japanese Society for Neonatal Screening (JSNS) and a director of the Japanese Society for Inherited Metabolic Diseases (JSIMD). He received the JSIMD Encouragement Award in 2009 and the JSIMD Sanofi Academic Grant in 2017. His clinical and research interests include the enzymatic and genetic evaluation and clinical management of targeted diseases in expanded newborn screening, especially fatty acid oxidation disorders.